Tetrabenazine Racemate
CAS No. 718635-93-9
Tetrabenazine Racemate( Ro 1-9569 Racemate )
Catalog No. M19033 CAS No. 718635-93-9
Tetrabenazine (Racemate) is a selective and reversible inhibitor of vesicular monoamine transporter-2 (VMAT-2).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 41 | In Stock |
|
| 25MG | 75 | In Stock |
|
| 50MG | 112 | In Stock |
|
| 100MG | 149 | In Stock |
|
| 200MG | 194 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTetrabenazine Racemate
-
NoteResearch use only, not for human use.
-
Brief DescriptionTetrabenazine (Racemate) is a selective and reversible inhibitor of vesicular monoamine transporter-2 (VMAT-2).
-
DescriptionTetrabenazine (Racemate) is a selective and reversible inhibitor of vesicular monoamine transporter-2 (VMAT-2). Tetrabenazine blocks neurotransmitter uptake into adrenergic storage vesicles and has been used as a high-affinity label for the vesicle transport system.
-
In Vitro——
-
In Vivo——
-
SynonymsRo 1-9569 Racemate
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
RecptorVMAT-2
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number718635-93-9
-
Formula Weight317.43
-
Molecular FormulaC19H27NO3
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 3.2 mg/mL; 10.08 mM
-
SMILESCC(C)CC1CN2CCc3cc(c(cc3C2CC1=O)OC)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jankovic, J. and J. Beach, Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology, 1997. 48(2): p. 358-62.
molnova catalog
related products
-
DOV 21947 hydrochlor...
Amitifadine hydrochloride is a triple reuptake inhibitor (TRI) or serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI).
-
Chlorprothixene hydr...
Chlorprothixene is a typical antipsychotic drug of the thioxanthene (tricyclic) class.
-
SB1317
SB1317 is a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3).
Cart
sales@molnova.com